Logo

Harvard Bioscience Acquires BioRobotics for $3.2M

Sep 22, 2003

NEW YORK, Sept. 22 (GenomeWeb News) - Harvard Bioscience said Friday that its Genomic Solutions subsidiary had acquired microarray instrumentation firm BioRobotics, a subsidiary of Apogent Technologies, for approximately $3.2 million in cash and certain limited liabilities.

BioRobotics sells robotics for DNA microarray manufacturing and colony picking. Jeff Williams, president of Genomic Solutions, said the Cambridge, UK-based firm's product line would complement that of GeneMachines, a company it acquired last March for $8.3 million, with "GeneMachines' strength in high-capacity arrayers and BioRobotics' strength in bench top instruments."

Williams said that BioRobotics' UK-based support and sales staff will join Genomic Solutions' UK sales and marketing team, while product development and manufacturing will be consolidated into the company's Huntingdon, UK facility.

BioRobotics is expected to achieve revenues of approximately $3 million in 2004.

Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.